Reemergence of Measles in the Americas: The Genotype B3 2011-2012 Outbreak in Ecuador.
- Published in:
- Vaccines, 2017, v. 5, n. 2, p. 15, doi. 10.3390/vaccines5020015
- By:
- Publication type:
- Article
Works matching IS 2076393X AND DT 2017 AND VI 5 AND IP 2
Results: 7
1
2
Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?
- Published in:
- Vaccines, 2017, v. 5, n. 2, p. 14, doi. 10.3390/vaccines5020014
- By:
- Publication type:
- Article
3
The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States.
- Published in:
- Vaccines, 2017, v. 5, n. 2, p. 13, doi. 10.3390/vaccines5020013
- By:
- Publication type:
- Article
4
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.
- Published in:
- Vaccines, 2017, v. 5, n. 2, p. 10, doi. 10.3390/vaccines5020010
- By:
- Publication type:
- Article
5
Unexpected Infection Spikes in a Model of Respiratory Syncytial Virus Vaccination.
- Published in:
- Vaccines, 2017, v. 5, n. 2, p. 11, doi. 10.3390/vaccines5020012
- By:
- Publication type:
- Article
6
The Effect of Physicochemical Modification on the Function of Antibodies Induced by Anti-Nicotine Vaccine in Mice.
- Published in:
- Vaccines, 2017, v. 5, n. 2, p. 11, doi. 10.3390/vaccines5020011
- By:
- Publication type:
- Article
7
Oncolytic Alphaviruses in Cancer Immunotherapy.
- Published in:
- Vaccines, 2017, v. 5, n. 2, p. 9, doi. 10.3390/vaccines5020009
- By:
- Publication type:
- Article